查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1378917

2023-2028 年監管事務外包市場報告（按服務、公司規模、類別、適應症、階段（臨床前、臨床、PMA）、最終用戶和地區）

Regulatory Affairs Outsourcing Market Report by Services, Company Size, Category, Indication, Stage (Preclinical, Clinical, PMA ), End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球監管事務外包市場規模達到71億美元。展望未來， IMARC Group預計到2028年市場規模將達到117億美元，2022-2028年複合年成長率（CAGR）為8.7%。不斷發展和複雜的法規、行業全球化、資源最佳化、持續的技術進步、專業知識要求以及快速核准的需要是推動市場的一些主要因素。

監管事務外包是公司將其監管合規和文件任務委託給外部專業服務提供者的做法。在這種安排下，企業，特別是製藥、生物技術和醫療器材等高度監管行業的企業，聘請第三方專家或公司代表其管理監管事務。這包括產品註冊、品質保證、遵守政府法規以及向監管機構提交所需文件等活動。外包這些任務使公司能夠利用精通監管框架的專業人士的專業知識，簡化流程，降低管理成本，並確保遵守不斷變化的監管標準，最終促進市場進入和產品批准。

全球監管事務外包市場正在經歷大幅成長，這主要是由於政府和監管機構對各個行業（包括製藥、醫療器材以及食品和飲料（F&B））提出的日益複雜和嚴格的監管要求。此外，不斷擴大的產品採用使公司能夠獲得一群精通最新監管變化和合規標準的專業人士，從而確保及時批准和市場准入，這有助於市場成長。此外，市場全球化擴大了企業的地理範圍，需要遵守多種國際法規，進而促進市場成長。此外，對外包提供可擴展解決方案以滿足跨地區不同監管需求的需求不斷成長，這有助於市場擴張。除此之外，成本效率和營運彈性的新興趨勢促使公司利用外部監管服務，使他們能夠專注於核心競爭力，同時減少管理費用，從而為市場擴張創造積極的前景。

監理事務外包市場趨勢/促進因素：

監管環境日益複雜

監管事務外包的主要驅動力之一是各行業日益複雜且不斷變化的監管環境。製藥、生物技術、醫療器材以及食品和飲料 (F&B) 等行業受到嚴格的監管，以確保產品安全、功效並符合品質標準。遵守這些法規需要專業知識和持續監控。外包監管事務使公司能夠利用專門了解區域和國際監管框架細微差別的專業人士的專業知識。除此之外，這些專家還幫助企業駕馭複雜的規則網路，確保其產品符合合規標準，最終促進市場准入和產品批准。

擴大市場全球化

推動監管事務外包成長的另一個關鍵因素是市場的全球化。隨著企業在全球擴展業務，他們會遇到因地區和國家而異的各種監管要求。遵守這些法規可能是一項艱鉅的任務，特別是對於內部監管資源有限的公司。同時，外包提供了一個可擴展的解決方案，可以有效地滿足這些不同的監管需求。監管事務外包公司通常具有全球影響力，可以幫助企業調整其產品和流程，以滿足不同市場的特定要求，從而實現市場准入和國際成長。

日益關注成本效率和營運生產力

成本效率和對營運重點的需求正在推動公司利用外部監管服務。維持內部監管事務團隊涉及大量管理費用，包括薪資、培訓和基礎設施。外包監管事務使組織能夠降低這些固定成本並獲得資源分配的靈活性。這種方法使公司能夠將資源轉向研發 (R&D)、行銷和生產等核心能力。透過將監管活動委託給專業的外包合作夥伴，企業可以簡化營運、提高效率並更有效地應對市場動態。

監理事務外包產業細分：

IMARC Group提供了全球監管事務外包市場報告各細分市場主要趨勢的分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據服務、公司規模、類別、適應症、階段和最終用戶對市場進行了分類。

按服務細分：

監理諮詢

法律代表

監理寫作和出版

產品註冊及臨床試驗申請

其他

監理寫作和出版主導市場

該報告根據服務提供了詳細的市場細分和分析。這包括監管諮詢、法律代表、監管寫作和出版、產品註冊和臨床試驗申請等。根據該報告，監管寫作和出版佔據了最大的部分。

監管文件日益複雜，推動了對監管寫作和出版外包的需求，這需要專門的專業知識和資源。隨著監管要求變得更加複雜且針對特定地區，企業尋求對文件準備和提交流程有深入了解的外部合作夥伴。除此之外，快速核准和市場准入的需求迫使公司將這些關鍵任務外包，以確保準確、合規和及時的提交。此外，電子提交系統的採用和監管流程的數位轉型對外包提供者產生了需求，這些外包供應商擁有高效電子文件準備和發布所需的技術基礎設施和熟練程度。

按公司規模分類：

小的

中等的

大的

Medium 佔據最大市場佔有率

報告還根據公司規模對市場進行了詳細的細分和分析。這包括小型、中型和大型。報告稱，媒介佔據了最大的市場。

推動全球監管事務外包市場的另一個關鍵因素是中型企業對專業知識和資源最佳化的需求不斷成長。中型企業經常面臨資源限制，並且可能缺乏對不斷變化的法規具有全面了解的內部監管事務團隊。外包使他們能夠接觸到一群經驗豐富的監管專業人員，而無需承擔維持全職團隊的管理費用。此外，隨著這些公司擴展到新市場，他們需要適應性強的監管支援來應對多樣化和複雜的監管環境，使外包成為確保合規性、市場准入和成長的高效策略選擇。

按類別細分：

學名藥

創新藥物

生物藥

生物相似藥

醫療設備

治療性

診斷

其他

醫療器材主導市場

該報告根據類別提供了詳細的市場細分和分析。這包括學名藥、創新藥、生物藥、生物相似藥、醫療器材（治療和診斷）等。根據該報告，醫療設備佔最大的部分。

醫療器材產業受到全球嚴格且不斷變化的監管要求的約束，需要專業知識來駕馭。外包提供了對醫療器材法規有深入了解的監管專業人員的聯繫，確保合規性和更快的批准。除此之外，醫療器材技術的不斷創新需要高效、及時的提交，以將新產品推向市場。外包簡化了監管流程，使公司能夠專注於研發，從而推動市場的成長。此外，隨著醫療器材市場的國際化，外包服務為產品適應不同的監管環境提供了支持，使得外包對於該行業的市場進入和持續成長不可或缺。

按指示細分：

腫瘤學

神經病學

心臟病學

免疫學

其他

腫瘤學佔據最大市場佔有率

報告還提供了基於指示的詳細市場細分和分析。這包括腫瘤學、神經學、心臟病學、免疫學等。報告稱，腫瘤學佔據最大的市場佔有率。

該治療領域的獨特挑戰和快速進步正在推動腫瘤學領域對監管事務外包的需求。腫瘤產品通常會加速開發，並且由於其潛在的挽救生命的性質而需要加快監管途徑。這需要外包合作夥伴可以提供腫瘤學特定法規和快速核准流程的專業知識。此外，腫瘤臨床試驗日益複雜，並且需要全面的資料管理和提交，因此需要外包給能夠駕馭這些複雜的監管環境的專家，以確保關鍵腫瘤治療的及時批准和市場准入。

按階段分類：

臨床前

臨床

PMA（上市後授權）

臨床主導市場

該報告根據階段對市場進行了詳細的細分和分析。這包括臨床前、臨床和上市後授權 (PMA)。根據該報告，臨床代表了最大的部分。

臨床試驗日益複雜和資源密集的性質導致臨床階段監管事務外包的需求不斷增加。從事臨床研究的公司必須遵守嚴格的監管要求，以確保研究產品的安全性和有效性。外包為監管專業人員提供了接觸臨床試驗法規和文件專業知識的機會，幫助公司有效應對這一複雜的環境。同時，快速研究啟動和遵守不斷變化的監管標準的需求推動了對方案開發、提交和合規性外包支援的需求，以確保臨床試驗順利進展並有效滿足監管里程碑。

按最終用戶分類：

醫療器材公司

製藥公司

生技公司

製藥公司佔最大的市場佔有率

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫療器材、製藥和生技公司。報告顯示，製藥公司佔了最大的市場佔有率。

製藥業不斷發展的格局是幫助市場擴張的關鍵因素。隨著對創新藥物開發和嚴格監管的日益重視，製藥公司需要專業知識來應對複雜的監管途徑。外包提供了熟悉藥品法規的監管專業人員的機會，加快了核准流程並確保合規性。此外，全球市場准入的需求和適應區域監管差異的需求使外包成為一個有吸引力的選擇。它使製藥公司能夠專注於核心研發活動，而外部合作夥伴則有效率且有效地處理監管事務。

按地區分類：

北美洲

美國

加拿大

亞太地區

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

亞太地區佔據明顯主導地位，佔據最大的監管事務外包市場佔有率

市場研究報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告顯示，亞太地區佔據最大的市場佔有率。

亞太地區製藥、醫療保健和生命科學產業的日益全球化導致對監管服務的需求激增，以因應該地區不同的監管環境。同時，該地區臨床試驗和研究活動數量的不斷增加需要當地監管要求的專業知識，這使得外包成為尋求擴大業務的製藥和生物技術公司的有效解決方案。此外，隨著公司尋求在不影響合規性的情況下最佳化資源，成本效率發揮關鍵作用，這使得監管事務外包成為亞太地區有吸引力的選擇。

競爭格局：

全球監管事務外包市場競爭格局的特徵是參與者活躍且多元化，爭奪市場佔有率。大型跨國合約研究組織 (CRO) 佔據重要地位，為各個行業和地區提供全面的監管服務。這些行業巨頭利用其廣泛的全球網路、強大的技術平台和深厚的監管專業知識來滿足客戶的多樣化需求。此外，利基和專業的監管事務外包公司專注於特定行業或地區，提供量身定做的解決方案和深入的監管知識。包括新創公司和區域服務提供者在內的新興參與者也透過利用市場利基和創新服務產品而獲得吸引力。隨著公司尋求擴大其服務組合和地理覆蓋範圍，策略合作、併購進一步塑造了競爭格局。

該報告對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

查爾斯河實驗室國際公司

科文斯公司（美國實驗室控股公司）

弗雷爾

圖示公司

梅德佩斯控股公司

精銳國際公司

醫藥產品開發股份有限公司

Promedica International- 加州公司

無錫藥明康德有限公司

最近的發展：

2021 年 2 月，ICON plc 宣布以現金和股票交易收購 PRA Health Sciences, Inc.，價值約 120 億美元。此次收購增強了公司的醫療事務服務能力。

本報告回答的關鍵問題：

  • 迄今為止，全球監管事務外包市場的表現如何，未來幾年將如何表現？
  • COVID-19 對全球監管事務外包市場有何影響？
  • 主要區域市場有哪些？
  • 基於服務的市場區隔是什麼？
  • 依公司規模分類的市場是怎麼樣的？
  • 根據類別分類的市場是怎麼樣的？
  • 根據指示，市場的細分是什麼？
  • 基於階段的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球監管事務外包市場的架構如何？主要參與者是誰？
  • 產業競爭程度如何？

本報告回答的關鍵問題：

  • 迄今為止，全球監管事務外包市場的表現如何，未來幾年將如何表現？
  • COVID-19 對全球監管事務外包市場有何影響？
  • 主要區域市場有哪些？
  • 基於服務的市場區隔是什麼？
  • 依公司規模分類的市場是怎麼樣的？
  • 根據類別分類的市場是怎麼樣的？
  • 根據指示，市場的細分是什麼？
  • 基於階段的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球監管事務外包市場的架構如何？主要參與者是誰？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球監理事務外包市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按服務分類的市場區隔

  • 監理諮詢
    • 市場走向
    • 市場預測
  • 法律代表
    • 市場走向
    • 市場預測
  • 監理寫作和出版
    • 市場走向
    • 市場預測
  • 產品註冊及臨床試驗申請
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按公司規模分類的市場細分

  • 小的
    • 市場走向
    • 市場預測
  • 中等的
    • 市場走向
    • 市場預測
  • 大的
    • 市場走向
    • 市場預測

第 8 章：按類別分類的市場區隔

  • 學名藥
    • 市場走向
    • 市場預測
  • 創新藥物
    • 市場走向
    • 市場預測
  • 生物藥
    • 市場走向
    • 市場預測
  • 生物相似藥
    • 市場走向
    • 市場預測
  • 醫療設備
    • 市場走向
    • 主要類型
      • 治療性
      • 診斷
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按跡象分類的市場

  • 腫瘤學
    • 市場走向
    • 市場預測
  • 神經病學
    • 市場走向
    • 市場預測
  • 心臟病學
    • 市場走向
    • 市場預測
  • 免疫學
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：按階段分類的市場細分

  • 臨床前
    • 市場走向
    • 市場預測
  • 臨床
    • 市場走向
    • 市場預測
  • PMA（上市後授權）
    • 市場走向
    • 市場預測

第 11 章：最終用戶的市場區隔

  • 醫療器材公司
    • 市場走向
    • 市場預測
  • 製藥公司
    • 市場走向
    • 市場預測
  • 生技公司
    • 市場走向
    • 市場預測

第 12 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 13 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 14 章：價值鏈分析

第 15 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 16 章：價格分析

第17章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Charles River Laboratories International Inc.
    • Covance Inc (Laboratory Corporation of America Holdings)
    • Freyr
    • ICON Plc
    • Medpace Holdings Inc
    • Parexel International Corporation
    • Pharmaceutical Product Development LLC
    • Promedica International- A California Corporation
    • Wuxi AppTec Co. Ltd.
Product Code: SR112023A3231

Abstract

The global regulatory affairs outsourcing market size reached US$ 7.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.7% during 2022-2028. The evolving and complex regulations, globalization of industries, resource optimization, ongoing technological advancements, specialized expertise requirements, and the need for rapid approvals are some of the major factors propelling the market.

Regulatory affairs outsourcing is the practice of companies delegating their regulatory compliance and documentation tasks to external specialized service providers. In this arrangement, businesses, particularly those in highly regulated industries such as pharmaceuticals, biotechnology, and medical devices, hire third-party experts or firms to manage regulatory affairs on their behalf. This encompasses activities like product registration, quality assurance, compliance with government regulations, and submission of required documentation to regulatory authorities. Outsourcing these tasks allows companies to tap into the expertise of professionals well-versed in regulatory frameworks, streamline processes, reduce overhead costs, and ensure adherence to evolving regulatory standards, ultimately facilitating market entry and product approval.

The global regulatory affairs outsourcing market is experiencing substantial growth primarily due to the increasingly complex and stringent regulatory requirements imposed by governments and regulatory bodies across various industries, including pharmaceuticals, medical devices, and food and beverages (F&B). Moreover, the expanding product adoption to enable companies to access a pool of professionals well-versed in the latest regulatory changes and compliance standards, thereby ensuring timely approvals and market access, is contributing to the market growth. Additionally, the globalization of markets has expanded the geographical reach of businesses, necessitating compliance with a multitude of international regulations, thereby bolstering the market growth. Furthermore, the growing need for outsourcing to provide a scalable solution to address diverse regulatory needs across regions is aiding in market expansion. Apart from this, the emerging trend toward cost-efficiency and operational flexibility drives companies to leverage external regulatory services, allowing them to focus on core competencies while mitigating overhead expenses, creating a positive outlook for market expansion.

Regulatory Affairs Outsourcing Market Trends/Drivers:

Increasing complexity in the regulatory landscape

One of the primary drivers of regulatory affairs outsourcing is the increasingly intricate and ever-evolving regulatory environment across various sectors. Industries such as pharmaceuticals, biotechnology, medical devices, and food and beverages (F&B) are subject to strict regulations to ensure product safety, efficacy, and compliance with quality standards. Keeping up with these regulations demands specialized knowledge and continuous monitoring. Outsourcing regulatory affairs allows companies to tap into the expertise of professionals who specialize in understanding the nuances of regional and international regulatory frameworks. Apart from this, these experts help businesses navigate the complex web of rules and ensure that their products meet compliance standards, ultimately facilitating market entry and product approval.

Expanding globalization of markets

Another pivotal factor fueling the growth of regulatory affairs outsourcing is the globalization of markets. As businesses expand their operations globally, they encounter a diverse array of regulatory requirements that vary by region and country. Complying with these regulations can be an intimidating task, especially for companies with limited in-house regulatory resources. In confluence with this, outsourcing provides a scalable solution to address these diverse regulatory needs efficiently. Regulatory affairs outsourcing firms often have a global presence and can assist businesses in adapting their products and processes to meet the specific requirements of different markets, thereby enabling market access and international growth.

Rising focus on cost-efficiency and operational productivity

Cost efficiency and the need for operational focus are driving companies to leverage external regulatory services. Maintaining an in-house regulatory affairs team involves substantial overhead costs, including salaries, training, and infrastructure. Outsourcing regulatory affairs allows organizations to reduce these fixed costs and gain flexibility in resource allocation. This approach enables companies to redirect resources towards core competencies such as research and development (R&D), marketing, and production. By entrusting regulatory activities to specialized outsourcing partners, businesses can streamline their operations, increase efficiency, and respond more effectively to market dynamics.

Regulatory Affairs Outsourcing Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global regulatory affairs outsourcing market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on services, company size, category, indication, stage and end user.

Breakup by Services:

Regulatory Consulting

Legal Representation

Regulatory Writing and Publishing

Product Registration and Clinical Trial Applications

Others

Regulatory writing and publishing dominate the market

The report has provided a detailed breakup and analysis of the market based on the services. This includes regulatory consulting, legal representation, regulatory writing and publishing, product registration and clinical trial applications, and others. According to the report, regulatory writing and publishing represented the largest segment.

The demand for regulatory writing and publishing outsourcing is driven by the growing complexity of regulatory documentation, which necessitates specialized expertise and resources. As regulatory requirements become more intricate and region-specific, businesses seek external partners with in-depth knowledge of document preparation and submission processes. Besides this, the need for rapid approvals and market access compels companies to outsource these critical tasks to ensure accurate, compliant, and timely submissions. Furthermore, the adoption of electronic submission systems and the digital transformation of regulatory processes create demand for outsourcing providers with the technological infrastructure and proficiency required for efficient electronic document preparation and publishing.

Breakup by Company Size:

Small

Medium

Large

Medium holds the largest share of the market

A detailed breakup and analysis of the market based on the company size have also been provided in the report. This includes small, medium, and large. According to the report, medium accounted for the largest market share.

Another key factor driving the global regulatory affairs outsourcing market is the rising demand for specialized expertise and resource optimization in medium-sized companies. Medium-sized firms often face resource constraints and may lack an in-house regulatory affairs team with comprehensive knowledge of evolving regulations. Outsourcing enables them to access a pool of experienced regulatory professionals without the overhead costs of maintaining a full-time team. Additionally, as these companies expand into new markets, they require adaptable regulatory support to navigate diverse and complex regulatory landscapes, making outsourcing an efficient and strategic choice to ensure compliance, market entry, and growth.

Breakup by Category:

Generic Drugs

Innovator Drugs

Biologic Drugs

Biosimilars

Medical Devices

Therapeutic

Diagnostic

Others

Medical devices dominate the market

The report has provided a detailed breakup and analysis of the market based on the category. This includes generic drugs, innovator drugs, biologic drugs, biosimilars, medical devices (therapeutic and diagnostic), and others. According to the report, medical devices represented the largest segment.

The medical devices sector is subject to rigorous and evolving regulatory requirements globally, requiring specialized expertise to navigate. Outsourcing offers access to regulatory professionals who possess in-depth knowledge of medical device regulations, ensuring compliance and quicker approvals. Besides this, the constant innovation in medical device technology demands efficient and timely submissions to bring new products to market. Outsourcing streamlines regulatory processes, allowing companies to focus on R&D, thereby fueling the market's growth. Moreover, as the medical device market expands internationally, outsourced services provide support in adapting products to diverse regulatory environments, making outsourcing indispensable for market entry and sustained growth in this sector.

Breakup by Indication:

Oncology

Neurology

Cardiology

Immunology

Others

Oncology holds the largest share of the market

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes oncology, neurology, cardiology, immunology, and others. According to the report, oncology accounted for the largest market share.

The unique challenges and rapid advancements in this therapeutic area are impelling the demand for regulatory affairs outsourcing in the field of oncology. Oncological products often undergo accelerated development and require expedited regulatory pathways due to their potential life-saving nature. This demands specialized knowledge of oncology-specific regulations and fast-track approval processes, which outsourcing partners can provide. Furthermore, the increasing complexity of oncology clinical trials and the need for comprehensive data management and submissions necessitate outsourcing to experts who can navigate these intricate regulatory landscapes, ensuring timely approvals and market access for critical oncology treatments.

Breakup by Stage:

Preclinical

Clinical

PMA (Post Market Authorization)

Clinical dominates the market

The report has provided a detailed breakup and analysis of the market based on the stage. This includes preclinical, clinical, and post market authorization (PMA). According to the report, clinical represented the largest segment.

The surging complexity and resource-intensive nature of clinical trials are contributing to the increasing demand for regulatory affairs outsourcing at the clinical stage. Companies engaging in clinical research must adhere to stringent regulatory requirements to ensure the safety, security, and efficacy of investigational products. Outsourcing offers access to regulatory professionals with specialized knowledge of clinical trial regulations and documentation, helping companies navigate this intricate landscape efficiently. Concurrently, the need for rapid study initiation and adherence to evolving regulatory standards drives the demand for outsourced support in protocol development, submissions, and compliance, ensuring that clinical trials progress smoothly and meet regulatory milestones effectively.

Breakup by End User:

Medical Device Companies

Pharmaceutical Companies

Biotechnology Companies

Pharmaceutical companies hold the largest share of the market

A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes medical device, pharmaceutical, and biotechnology companies. According to the report, pharmaceutical companies accounted for the largest market share.

The pharmaceutical industry's evolving landscape represents the key factor aiding in market expansion. With an increasing emphasis on innovative drug development and stringent regulatory oversight, pharmaceutical firms require specialized expertise to navigate the complex regulatory pathways. Outsourcing provides access to regulatory professionals well-versed in pharmaceutical regulations, speeding up the approval process and ensuring compliance. Moreover, the demand for global market access and the need to adapt to regional regulatory variations make outsourcing an attractive option. It enables pharmaceutical companies to focus on core research and development activities while external partners handle regulatory affairs efficiently and effectively.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Asia-Pacific exhibits a clear dominance, accounting for the largest regulatory affairs outsourcing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia-Pacific accounted for the largest market share.

The increasing globalization of the pharmaceutical, healthcare, and life sciences sectors across the Asia Pacific has led to a surge in demand for regulatory services to navigate diverse regulatory landscapes across the region. Concurrent with this, the rising number of clinical trials and research activities in the region necessitates expertise in local regulatory requirements, making outsourcing an efficient solution for pharmaceutical and biotech companies looking to expand their presence. Furthermore, cost-efficiency plays a pivotal role as companies seek to optimize resources without compromising on compliance, making regulatory affairs outsourcing an attractive option in the Asia Pacific region.

Competitive Landscape:

The competitive landscape of the global regulatory affairs outsourcing market is characterized by a dynamic and diverse array of players vying for market share. Large multinational contract research organizations (CROs) hold prominent positions, offering comprehensive regulatory services across various industries and geographies. These industry giants leverage their extensive global networks, robust technology platforms, and deep regulatory expertise to cater to the diverse needs of clients. Additionally, niche and specialized regulatory affairs outsourcing firms focus on specific industries or regions, offering tailored solutions and in-depth regulatory knowledge. Emerging players, including startups and regional service providers, are also gaining traction by capitalizing on market niches and innovative service offerings. The competitive landscape is further shaped by strategic collaborations, mergers, and acquisitions as companies seek to expand their service portfolios and geographic reach.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Charles River Laboratories International Inc.

Covance Inc (Laboratory Corporation of America Holdings)

Freyr

ICON Plc

Medpace Holdings Inc.

Parexel International Corporation

Pharmaceutical Product Development LLC

Promedica International- A California Corporation

Wuxi AppTec Co. Ltd.

Recent Developments:

In February 2021, ICON plc announced the acquisition of PRA Health Sciences, Inc. in a cash and stock transaction valued at USD 12 billion approximately. This acquisition has strengthened the medical affairs service offering of the company.

Key Questions Answered in This Report:

  • How has the global regulatory affairs outsourcing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global regulatory affairs outsourcing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the services?
  • What is the breakup of the market based on the company size?
  • What is the breakup of the market based on the category?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the stage?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global regulatory affairs outsourcing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Regulatory Affairs Outsourcing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Services

  • 6.1 Regulatory Consulting
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Legal Representation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Regulatory Writing and Publishing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Product Registration and Clinical Trial Applications
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Company Size

  • 7.1 Small
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medium
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Large
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Category

  • 8.1 Generic Drugs
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Innovator Drugs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Biologic Drugs
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Biosimilars
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Medical Devices
    • 8.5.1 Market Trends
    • 8.5.2 Major Types
      • 8.5.2.1 Therapeutic
      • 8.5.2.2 Diagnostic
    • 8.5.3 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Indication

  • 9.1 Oncology
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Neurology
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cardiology
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Immunology
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Stage

  • 10.1 Preclinical
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 PMA (Post Market Authorization)
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Medical Device Companies
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Pharmaceutical Companies
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Biotechnology Companies
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Charles River Laboratories International Inc.
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
      • 17.3.1.3 Financials
      • 17.3.1.4 SWOT Analysis
    • 17.3.2 Covance Inc (Laboratory Corporation of America Holdings)
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 SWOT Analysis
    • 17.3.3 Freyr
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
    • 17.3.4 ICON Plc
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 Financials
      • 17.3.4.4 SWOT Analysis
    • 17.3.5 Medpace Holdings Inc
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
      • 17.3.5.3 Financials
      • 17.3.5.4 SWOT Analysis
    • 17.3.6 Parexel International Corporation
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
      • 17.3.6.3 SWOT Analysis
    • 17.3.7 Pharmaceutical Product Development LLC
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 Financials
      • 17.3.7.4 SWOT Analysis
    • 17.3.8 Promedica International- A California Corporation
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
    • 17.3.9 Wuxi AppTec Co. Ltd.
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Regulatory Affairs Outsourcing Market: Major Drivers and Challenges
  • Figure 2: Global: Regulatory Affairs Outsourcing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Regulatory Affairs Outsourcing Market: Breakup by Services (in %), 2022
  • Figure 5: Global: Regulatory Affairs Outsourcing Market: Breakup by Company Size (in %), 2022
  • Figure 6: Global: Regulatory Affairs Outsourcing Market: Breakup by Category (in %), 2022
  • Figure 7: Global: Regulatory Affairs Outsourcing Market: Breakup by Indication (in %), 2022
  • Figure 8: Global: Regulatory Affairs Outsourcing Market: Breakup by Stage (in %), 2022
  • Figure 9: Global: Regulatory Affairs Outsourcing Market: Breakup by End User (in %), 2022
  • Figure 10: Global: Regulatory Affairs Outsourcing Market: Breakup by Region (in %), 2022
  • Figure 11: Global: Regulatory Affairs Outsourcing (Regulatory Consulting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Regulatory Affairs Outsourcing (Regulatory Consulting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Regulatory Affairs Outsourcing (Legal Representation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Regulatory Affairs Outsourcing (Legal Representation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Regulatory Affairs Outsourcing (Regulatory Writing and Publishing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Regulatory Affairs Outsourcing (Regulatory Writing and Publishing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Regulatory Affairs Outsourcing (Product Registration and Clinical Trial Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Regulatory Affairs Outsourcing (Product Registration and Clinical Trial Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Regulatory Affairs Outsourcing (Other Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Regulatory Affairs Outsourcing (Other Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Regulatory Affairs Outsourcing (Small) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Regulatory Affairs Outsourcing (Small) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Regulatory Affairs Outsourcing (Medium) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Regulatory Affairs Outsourcing (Medium) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Regulatory Affairs Outsourcing (Large ) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Regulatory Affairs Outsourcing (Large ) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Regulatory Affairs Outsourcing (Generic Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Regulatory Affairs Outsourcing (Generic Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Regulatory Affairs Outsourcing (Innovator Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Regulatory Affairs Outsourcing (Innovator Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Regulatory Affairs Outsourcing (Biologic Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Regulatory Affairs Outsourcing (Biologic Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Regulatory Affairs Outsourcing (Biosimilars) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Regulatory Affairs Outsourcing (Biosimilars) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Regulatory Affairs Outsourcing (Medical Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Regulatory Affairs Outsourcing (Medical Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Regulatory Affairs Outsourcing (Other Categories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Regulatory Affairs Outsourcing (Other Categories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Regulatory Affairs Outsourcing (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Regulatory Affairs Outsourcing (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Regulatory Affairs Outsourcing (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Regulatory Affairs Outsourcing (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Regulatory Affairs Outsourcing (Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Regulatory Affairs Outsourcing (Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Regulatory Affairs Outsourcing (Immunology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Regulatory Affairs Outsourcing (Immunology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Regulatory Affairs Outsourcing (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Regulatory Affairs Outsourcing (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Regulatory Affairs Outsourcing (Preclinical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Regulatory Affairs Outsourcing (Preclinical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Global: Regulatory Affairs Outsourcing (Clinical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Global: Regulatory Affairs Outsourcing (Clinical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Global: Regulatory Affairs Outsourcing (PMA -Post Market Authorization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Global: Regulatory Affairs Outsourcing (PMA -Post Market Authorization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Global: Regulatory Affairs Outsourcing (Medical Device Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Global: Regulatory Affairs Outsourcing (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Global: Regulatory Affairs Outsourcing (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Global: Regulatory Affairs Outsourcing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Global: Regulatory Affairs Outsourcing (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Global: Regulatory Affairs Outsourcing (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: North America: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: North America: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: United States: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: United States: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Canada: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Canada: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Asia-Pacific: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Asia-Pacific: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: China: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: China: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Japan: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Japan: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: India: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: India: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: South Korea: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: South Korea: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Australia: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Australia: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Indonesia: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Indonesia: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Europe: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Europe: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Germany: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Germany: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: France: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: France: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: United Kingdom: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: United Kingdom: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Italy: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Italy: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Spain: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Spain: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Russia: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Russia: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Others: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Others: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Latin America: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 100: Latin America: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 101: Brazil: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 102: Brazil: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 103: Mexico: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 104: Mexico: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 105: Others: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 106: Others: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 107: Middle East and Africa: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 108: Middle East and Africa: Regulatory Affairs Outsourcing Market: Breakup by Country (in %), 2022
  • Figure 109: Middle East and Africa: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 110: Global: Regulatory Affairs Outsourcing Industry: SWOT Analysis
  • Figure 111: Global: Regulatory Affairs Outsourcing Industry: Value Chain Analysis
  • Figure 112: Global: Regulatory Affairs Outsourcing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Regulatory Affairs Outsourcing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Services (in Million US$), 2023-2028
  • Table 3: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Company Size (in Million US$), 2023-2028
  • Table 4: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Category (in Million US$), 2023-2028
  • Table 5: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 6: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Stage (in Million US$), 2023-2028
  • Table 7: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 8: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 9: Global: Regulatory Affairs Outsourcing Market: Competitive Structure
  • Table 10: Global: Regulatory Affairs Outsourcing Market: Key Players